← Feed

Troendle August J.

SEC Form 4 insider
President & CEO · Medpace Holdings, Inc. ($MEDP)
2 theses · first seen Aug 12, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d111100%-1.6%-1.6%
3d22150%+0.1%+0.1%
1w2200%+4.6%+4.6%
1m22150%-0.0%-0.0%
3m000———
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$MEDPSEC Form 4bearish
Troendle August J. · President & CEO at Medpace Holdings, Inc. · 67d ago1 prior · awaiting results
Sold 11,824 @ $601.49 avg · $7,111,969 · 2026-08-12

Form 4: Troendle August J. sold MEDP

Troendle August J. (President & CEO at Medpace Holdings, Inc.) reported an open-market sale of 11,824 shares of MEDP at an average $601.49, roughly $7,111,969, in a Form 4 filed 2026-08-14.

At post $578.50Now $614.80+6.3% since postedas of Aug 24, 1:28 PM ET
1d—
3d+3.2%
1w+7.3%
1m+1.6%
3m—
6m—
1y—
View filing on SEC.gov →
$MEDPSEC Form 4bearish
Troendle August J. · President & CEO at Medpace Holdings, Inc. · 69d ago1 prior · awaiting results
Sold 23,144 @ $604.25 avg · $13,984,854 · 2026-08-10

Form 4: Troendle August J. sold MEDP

Troendle August J. (President & CEO at Medpace Holdings, Inc.) reported an open-market sale of 23,144 shares of MEDP at an average $604.25, roughly $13,984,854, in a Form 4 filed 2026-08-12.

At post $596.98Now $614.80+3.0% since postedas of Aug 24, 1:28 PM ET
1d-1.6%
3d-3.1%
1w+1.9%
1m-1.6%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.